![Improving Burkitt lymphoma outcomes at every juncture. BL, Burkitt lymphoma; EBV, Epstein-Barr virus; FDG-PET, [18F]fluorodeoxyglucose positron emission tomography; LDH, lactate dehydrogenase; MRD, measurable residual disease.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/145/23/10.1182_blood.2025028549/2/blood_bld-2025-028549-c-gr1.jpeg?Expires=1752315874&Signature=3ae3OJoW7UW6~jrGN0iA7kwu~XbrvbK19ntqCKDnA9T95owkM1Jl9c17IKV4LEy6qjQFxI4VEeRXhTNyJiNPls8faWkcLWnv9D9EAqhcQX0CEH8Ec2MBAWmAOiKYBQxYKBgAihrtKM~rW8SogzPLcXMBY3Hve3gVXtVDkJl77Lx9u3wqn477CjdVglJRC30r~yrMTkLXjWYrOWsqf1oEZxA9U3D5xygOBIA0Ep6m9UhkbswfCeDzZTeQfkTujMZgSswV-BErqcpU3jT9CmbvIkGvbfyTLqkMFhq6M4uO9LQFEKVxlG9HoqvgzZA1K~iabQmDGK2N1~~0xvOUA5LqAg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Improving Burkitt lymphoma outcomes at every juncture. BL, Burkitt lymphoma; EBV, Epstein-Barr virus; FDG-PET, [18F]fluorodeoxyglucose positron emission tomography; LDH, lactate dehydrogenase; MRD, measurable residual disease.
Improving Burkitt lymphoma outcomes at every juncture. BL, Burkitt lymphoma; EBV, Epstein-Barr virus; FDG-PET, [18F]fluorodeoxyglucose positron emission tomography; LDH, lactate dehydrogenase; MRD, measurable residual disease.
